A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.

Private, personal, highly-sensitive patient data labelled on an envelope’s exterior for all to see enroute. In an era of identity theft. In a home that requires paper accommodations due to health. Our ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

Idorsia Ltd (SIX: IDIA) today announced that the US Food & Drug Administration (FDA), after having released TRYVIO from its REMS (Risk Evaluation and Mitigation Strategy) ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Users say they feel relief from burning feet, numb fingers, nerve zaps, and leg cramps within weeks. More impressively, many ...

Progressively interacting in this way with someone outside your relationship may be no big deal to you. To your significant ...

Identification of better targets -- combined with better precision and potency -- could make oral therapies preferred options for more patients with ... week 28 of an open-label extension, the ...

A doctor rushes to access a patient’s file in an emergency but instead finds a ransom note, blocking the treatment from even starting. That’s the kind of chaos ransomware can bring to hospitals. It ...

New research identifies two specific mixtures of common food additives linked to increased type 2 diabetes risk. Learn which ...